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ABSTRACT: Pituranthos chloranthus and Artemisia vulgaris L. are two of the 
most important aromatic and medicinal species from the Apiaceae and Asteraceae 
families, respectively. They are traditionally used in certain pathologies in which 
inflammatory processes are involved. The present study investigates the potential of 
aqueous extracts of Tunisian P. chloranthus and A. vulgaris as a natural alternative 
source of antioxidant and anti-inflammatory activities using in-vitro techniques. The 
antioxidant activities of aqueous extracts were evaluated through several assays: 
capacity for scavenging free radicals (ABTS, DPPH, hydroxyl, superoxide, nitric 
oxide); and total antioxidant capacity by ferric reducing power activity and 
inhibition of lipid peroxidation by thiobarbituric acid reactive species (TBARS) 
method. The anti-inflammatory activity was evaluated through the lipoxygenase 
(LOX) inhibitory activity. P. chloranthos aqueous extract presented higher 
concentration of total phenols than A. vulgaris extract, nevertheless higher capacity 
for scavenging ABTS, superoxide, hydroxyl, and NO free radicals. In the presence 
of liver homogenate, both extracts had poorer antioxidant activity than in the 
remaining lipid substrates. P. chloranthos extract had a higher ability for inhibiting 
lipoxygenase twice higher than A. vulgaris, while it had lower capacity for reducing 
Fe3+ than P. chloranthos extract. Our results suggest that there are differences of 
antioxidant activity between both samples, but also the strength for inhibiting the 
oxidation is highly dependent on the method used. 
INTRODUCTION: Pituranthos chloranthus 
(Bent. Et Hook.) (Apiaceae) is an aromatic plant 
from North Africa.  
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This species grows naturally in central and 
southern Tunisia. The Arabian name of this species 
in this country is ‘Guezzah’ 1, 2 and ‘Aljen’ 3, 4. 
However, there is also an indication that ‘Guezzah’ 
is the Arabian name of P. scoparius 
5
 or P. 
tortuosus 
4, 6
. 
Over time, P. chloranthus has been used either in 
agriculture or as a remedy. In the agriculture, the 
stems can be used as a straw to dry figs and grapes 
or as insecticide or for disinfecting the underground 
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cisterns of the rainwater storage after suspending a 
tuft of the plant to the surface. In traditional 
medicine, the plant has been used for diverse 
purposes: treatment of pain, rheumatism, spasms, 
fever, digestive difficulties, hepatitis, urinary 
infections, and scorpion stings 
2
. However, there 
are authors, who attribute some of these 
applications to P. tortuosus 
6
 or P. scoparius 
5
. 
According to the review 
5
, P. chloranthus has only 
been traditionally used on diabetes and fever, 
whereas another author 
7
 indicates that this species 
is only used for combating headache after the 
application of cataplasms on head. 
The chemical composition, the antimicrobial, 
antioxidant, antimutagenic and anti-genotoxic 
properties of the essential oils of P. chloranthus 
from Tunisia have been the aim of the study of 
several authors 
1, 2, 4, 8, 9, 10, 11, 12
. Only very few 
reports 
13
 about the chemical composition of 
extracts of this species could be found: the 
flavonoids [isorhamnetin- 3- O- glucoside, 
isorhamnetin- 3- O-rutinoside, apigenin-6, 8-di-C-
glucoside (vicenin-2), and tamarixetin-3-O-
glucoside]. These flavonoids were obtained from 
extracts of the aerial parts of flowering P. 
chloranthus collected in Algeria 
13
. From Tunisia, 
the authors 
3
 identified coumarins, two in the aerial 
parts (isoimperatorin and osthol) and two other 
coumarins in the roots (bergapten and 
nodakenetin). The antioxidant and anti-microbial 
activities of extracts of P. chloranthus have also 
been reported 
14, 15
. 
Artemisia vulgaris L. (Asteraceae), known as 
mugwort or common wormwood, is an aromatic 
plant naturally growing in Europe, Africa and India 
16
. In addition, Hooper 
17 
refers ‘afsantin-e-hindi’ as 
the Arabian name given to Artemisia vulgaris L, 
whereas USAID; Chemonics International, Inc 
18
 
attributes ‘Chih’ as being the Arabian name for 
Artemisia vulgaris. On the other hand, there are 
also authors who attributed the name ‘Chih’ to the 
species A. herba-alba 
19
. In folk medicine, A. 
vulgaris is generally used as an antispasmodic, 
antiseptic, anthelmintic, carminative, sedative, and in 
the treatment of menstrual problems, irregular 
periods, menopause and premenstrual syndrome 
20, 
21
. In some other regions of the world (Nepal, 
Pakistan), the leaves of A. vulgaris also have other 
applications, such as stopping nose bleeding, to 
treat oral ulcers, ophthalmic diseases, malaria, and 
fevers, to prevent and to treat some types of allergic 
reactions 
22, 23
. 
Other properties have been reported for mugwort: 
antimicrobial 
24, 25
, antioxidant 
16, 24, 25
, anti-
inflammatory 
21, 26
, hepatoprotective 
27
, hypo-
lipidemic 
21
 and antihypertensive properties 
26
 
although some authors have advised against the use 
of A. vulgaris for this purpose 
28
. The antioxidant 
and antimicrobial activities of the mugwort extracts 
have led to use them for fabricating silver 
nanoparticles with high potential biomedical 
applications 
29
. The chemical composition and 
biological properties of essential oils of A. vulgaris 
have been deeply investigated 
16, 27, 30, 31, 32, 33
. 
Biological properties of extracts of this species 
have also been evaluated and reviewed 
21, 24, 25, 34, 35
 
nevertheless their chemical composition has been 
much less scrutinized 
16, 36, 37, 38
. 
As aforementioned, A. vulgaris and P. chloranthus 
have been used in folk medicine in certain 
pathologies in which inflammatory processes are 
involved. When there is an uncontrolled and 
excessive production of reactive oxygen species 
(ROS) a process called oxidative stress occurs. 
These ROS can react with biomolecules, such as 
lipids, proteins, and nucleic acids. Under hypoxia, 
mitochondrial respiratory chain produces nitric 
oxide (NO), which is able to generate other reactive 
nitrogen species (RNS), which in turn, can produce 
other reactive species.  
The reaction of all these reactive species with 
cellular lipids induces excessive lipid peroxidation 
products, such as lipid-derived aldehydes (e.g. 
malonaldehyde, 4-hydroxy-2-nonenal) that can be 
responsible for several oxidative stress-induced 
inflammatory diseases 
39, 40
. The capacity of 
compounds to prevent lipid peroxidation and/or 
generation of reactive species may contribute to 
retard, decrease or prevent inflammation. 
The present work aimed at evaluating the potential 
antioxidant and anti-inflammatory activities using 
in-vitro techniques of aqueous extracts of Tunisian 
A. vulgaris and P. chloranthus.  
MATERIALS AND METHODS: 
Plant Material and Preparation of Extracts: 
Plant material was collected in 2014 from natural 
Nasr et al., IJPSR, 2020; Vol. 11(2): 605-614.                                               E-ISSN: 0975-8232; P-ISSN: 2320-5148 
International Journal of Pharmaceutical Sciences and Research                                                                                607 
populations located at the Center of Tunisia. The 
plant specimens were identified by Prof. Mohamed 
Chaieb, a botanist in the Faculty of Sciences of 
Sfax-Tunisia, and vouchers specimens (AVU-2 for 
A. vulgaris and PCH-3 for P. chloranthus) 
deposited in the Higher Institute of Biotechnology 
of Sidi Thabet-Tunisia. Extraction was performed 
by decoction of 5 g of dried aerial parts of Tunisian 
A. vulgaris and P. chloranthus for 1 h in 100 mL of 
distilled water. The aqueous phases were 
centrifuged for 10 min, at 2,000 g, at 20 ºC and the 
supernatant was removed and kept at -20 ºC until 
the determination of total phenols and in vitro 
antioxidant activities. 
Determination of Total Phenols (Folin-
Ciocalteau): The total phenol content of the 
extracts was determined according to 
41
. Gallic acid 
was used as standard. The aqueous extracts (0.5 
mL) and 2 mL of sodium carbonate (75 g/L) were 
added to 2.5 mL of 10% (v/v) Folin-Ciocalteau 
reagent. After 60 min at room temperature, the 
absorbance was measured at 765 nm. Tests were 
carried out in triplicate and the results presented as 
mg gallic acid equivalent (GAE)/g. 
Determination of ABTS (2, 2'-azino-bis (3-
ethylbenzothiazoline-6-sulphonic acid) Radical 
Cation Scavenging Capacity: The ABTS radical 
cation decolorization assay was carried out using 
the previously reported methods 
41
 with slight 
modifications. The aqueous extracts (10 μL) at 
various concentrations was mixed with 990 μL 
diluted ABTS
.+
 solution. The absorbance at 734 nm 
was measured after reaction at room temperature 
for 6 min. The ability to scavenge the ABTS
.+
 was 
calculated using the formula: 
Scavenging activity (%) = [(A0 - A1) / A0] × 100 
Where A0 is the absorbance of the control (without 
sample) and A1 is the absorbance in the presence of 
the sample. Tests were carried out in triplicate and 
the inhibition percentage was plotted against 
extract concentration (w/v) and the results 
presented as IC50 values (concentration of extract 
able to prevent 50% of lipid peroxidation).  
Determination of DPPH (2, 2-diphenyl-1-
picrylhydrazyl) free radical scavenging activity 
(DPPH): The aqueous extracts (50 μL) at different 
concentrations were placed in a cuvette, and 2 mL 
of 60 mM methanolic solution of DPPH was 
added 
41
. Absorbance measurements were made at 
517 nm after 60 min of reaction at room 
temperature. The ability to scavenge the DPPH free 
radicals was calculated using the formula: 
Scavenging activity (%) = [(A0 - A1) / A0] × 100, 
where A0 is the absorbance of the control (without 
sample) and A1 is the absorbance in the presence of 
the sample. The values of IC50 were determined as 
reported above. Tests were carried out in triplicate 
and the results presented as IC50 values. 
Hydroxyl Radical Scavenging Activity: The 
assay of hydroxyl scavenging activity was 
performed as 
42
 with small modifications. Briefly, 
the reaction mixture was prepared using 10 mM 
FeSO4.7H2O, 10 mM EDTA, 10 mM 2-
deoxyribose, 0.1 M phosphate buffer and sample at 
different concentrations to give a total volume of 
1.8 mL. Finally, 200 μL of H2O2 was added to the 
mixture, which was incubated at 37 °C for 4 h. 
After this period, 1 ml trichloroacetic acid (2.8%) 
and 1 mL thiobarbituric acid (1%) was added and 
boiled for 10 min to develop the pink colored 
malondialdehyde–thiobarbituric acid. After 
cooling, its absorbance was measured at 520 nm. 
The hydroxyl scavenging activity (%) was 
calculated using the following equation: Inhibition 
= [(A0 - A1) / A0] × 100 where A0 is the absorbance 
of the control (without sample) and A1 is the 
absorbance in the presence of the sample. The 
values of IC50 were determined as reported above. 
Tests were carried out in triplicate and the results 
presented as IC50 values. 
Superoxide Anion Scavenging Activity (Non-
Enzymatic Method): Measurements of superoxide 
anion scavenging activity of samples and positive 
control were based on the method previously 
described 
41
. Superoxide anions were generated in a 
non-enzymatic phenazine methosulfate 
nicotinamide adenine dinucleotide (PMS/NADH) 
system by oxidation of NADH and assayed by 
reduction of nitroblue tetrazolium (NBT). The 
method involved mixing the aqueous extracts (25 
μL) at different concentrations with 25 μL nitroblue 
tetrazolium (0.42 mg/mL) and 25 μL NADH (1.32 
mg/mL) and ethanol (125 μL) followed by 25 μL 
phenazine methosulfate (PMS) (0.25 mg/mL). The 
absorbance was measured at 560 nm, after 10 min 
of reaction.  
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The superoxide scavenging activity (%) was 
calculated using the following equation: Inhibition 
= [(A0 - A1) / A0] × 100 where A0 is the absorbance 
of the control (without sample), and A1 is the 
absorbance in the presence of the sample. Tests 
were carried out in triplicate and the results 
presented as IC50 values. 
Nitric Oxide (NO) Scavenging Capacity: The NO 
scavenging activity of aqueous extracts was 
determinate according to 
41
. The aqueous extracts 
(75 μL) at diverse concentrations were added to 75 
μL of 10 mM sodium nitroprusside into a 96-well 
plate and left standing at ambient temperature for 
35 min. The reaction was initiated by adding Griess 
reagent [40 μL of sulfanilamide solution and 40 μL 
of N-1-napthylethylenediamine dihydrochloride 
(NED) solution] to the mixture. The absorbance 
was measured at 532 nm without previous 
incubation. The NO scavenging activity (%) was 
calculated using the following equation: Inhibition 
= [(A0 - A1) / A0] × 100 where A0 is the absorbance 
of the control (without sample) and A1 is the 
absorbance in the presence of the sample. Tests 
were carried out in triplicate, and the results 
presented as IC50 values. 
Inhibition of Lipid Peroxidation by 
Thiobarbituric Acid Reactive Species (TBARS) 
Method: This assay was performed using three 
distinct lipid substrates: egg yolk, liver, and 
liposomes. The assay was carried out as described 
by 
41
. Egg yolk or liver (100 mg/mL) (250 μL) 
homogenates were mixed with acetic acid (750 μL) 
and the solution of TBA (8 mg/mL) (750 μL) 
dissolved in sodium dodecyl sulfate (SDS) (11 
mg/mL), and 100 μL aqueous extracts at different 
concentrations. The mixtures were heated for one 
hour in water bath at 95 °C. After cooling, the final 
volume was adjusted to 2 mL by adding butanol 
followed by centrifugation for 10 min at 3,000 g. 
The absorbance of the upper layer was read at 532 
nm. The percentage of inhibition was calculated as 
follows: [(A0 − A1 / A0) × 100], in which A0 is the 
absorbance of the control reaction (without 
extract), and A1 is the absorbance of the extracts. 
Analyses were run in triplicate. The IC50 values 
were determined (concentration of extract able to 
prevent 50% of lipid peroxidation). The liposome 
solution was made as follows: 0.4 g lecithin in 80 
mL chloroform.  
This solution was dried and submitted to nitrogen 
flux for 30 s and then to vacuum for at least two 
hours until complete dryness. After that, the 
reaction was initiated by mixing 50 μL of different 
extract concentrations with 100 μL of liposome 
suspension, FeCl3 (100 μL, 4 mM) and 50 μL of 
ascorbic acid (0.018 mg/mL). After incubation at 
37 °C for one hour, 2 mL of TBA solution (0.6%) 
was added. The mixture was heated for 10 min at 
95 °C. Afterward, 2 mL butanol was added and the 
final solution was centrifuged for 5 min at 3,000 g. 
The percentage of inhibition and the IC50 values 
were calculated as described above. 
Ferric Reducing Power Activity: The reducing 
power of each extract at different concentrations 
was measured as previously reported 
41
. Fifty 
microliters of each sample were mixed to 0.5 mL of 
potassium phosphate buffer (200 mM, pH 6) and 
0.5 mL of potassium ferricyanide (1%). The 
mixtures were incubated in a water bath (50 °C), 
for 20 min. After this period, 0.5 mL of 
trichloroacetic acid (10%, w/v) was added to the 
cooled mixture and submitted to centrifugation at 
3,000 g, for 10 min. Finally, distilled water (0.5 
mL) and 0.1 mL FeCl3 (0.1%, w/v) were added to 
the supernatant and the absorbance was measured 
at 700 nm. The ferric reducing power capacities of 
the extracts were expressed graphically by plotting 
absorbance against concentration. 
Lipoxygenase (LOX) Inhibitory Activity: The 
inhibition of the lipoxygenase enzyme was 
performed as reported 
41
. The reaction was started 
with the mixture of 10 μL of aqueous extracts at 
different concentrations, 5 μL of enzyme solution 
(0.054 g/mL), 50 μL of linoleic acid (0.001 M) and 
borate buffer 937 μL (0.1 M, pH 9). The 
measurement of the absorbance was recorded at 
234 nm. The percentage of inhibition was 
calculated as follows: [(A0 − A1 / A0) × 100], in 
which A0 is the absorbance of the control reaction 
(without extract), and A1 is the absorbance of the 
extracts. Analyses were run in triplicate. The 
percentage of inhibition and the IC50 values were 
calculated as described above. 
Statistical Analysis: Statistical analysis was 
performed using the Statistical Package for the 
Social Sciences (SPSS) 23.0 software (SPSS Inc., 
Chicago, IL, USA). Statistical comparisons were 
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made with one-way ANOVA followed by Tukey 
multiple comparisons. The level of significance 
was set at P<0.05. The paired Student t-test was 
used in some tests to determine differences at 95% 
significance. 
RESULTS: Table 1 depicts the content of phenols 
and antioxidant activities, measured through 
diverse methods, of P. chloranthus and A. vulgaris 
aqueous extracts. The antioxidant activity is 
expressed in IC50 (concentration of the extract that 
is able to prevent 50% lipid peroxidation or to 
scavenge free radicals or to inhibit lipoxygenase 
activity). The lower the IC50 values are, the higher 
the antioxidant activities will be. 
TABLE 1: PHENOL CONTENT AND ANTIOXIDANT ACTIVITY OF AQUEOUS EXTRACTS OF A. VULGARIS 
AND P. CHLORANTHUS 
Sample Phenol Hydroxyl DPPH ABTS Superoxide Egg yolk 
(TBARS) 
Liposomes 
(TBARS) 
NO Liver 
(TBARS) 
Lipoxygenase 
P. 
chloranthos 
1.36 
±0.02* 
0.38 
±0.02de*** 
0.44 
±0.01d,ns 
0.58 
±0.03c*** 
1.57 
±0.05b*** 
0.18 
±0.07f,ns 
0.12 
±0.01f*** 
4.83 
±0.04a*** 
0.36 
±0.03e*** 
0.02 
±0.00g** 
A. vulgaris 0.91 
±0.18* 
0.17 
±0.00d*** 
0.47 
±0.03c,ns 
0.17 
±0.01d*** 
0.57 
±0.02b*** 
0.10 
±0.01e,ns 
0.06 
±0.01f*** 
2.30 
±0.01a*** 
0.57 
±0.01b*** 
0.04 
±0.00f** 
Values in the same row followed by the same letter are not significant different (P<0.05) by the Tukey’s multiple range test; 
Means ± standard deviation; *: Statistically significant differences between phenol content of A. vulgaris and P. chloranthus 
extracts (p≤0.05; t-Student test); **Statistically significant differences between antioxidant activities of A. vulgaris and P. 
chloranthus extracts (p≤0.01; t-Student test); ***Statistically significant differences between antioxidant activities of A. vulgaris 
and P. chloranthus extracts (p≤0.001; t-Student test); ns: not significant between the capacity for scavenging DPPH free radicals 
and preventing lipid peroxidation in the presence of egg yolk of A. vulgaris and P. chloranthus extracts. 
P. chloranthos aqueous extract presented higher 
concentration of total phenols than A. vulgaris 
extract, nevertheless higher capacity for scavenging 
ABTS, superoxide, hydroxyl, and NO free radicals, 
since IC50 values (0.17; 0.57; 0.17; and 2.30 
mg/mL, respectively) were lower than those of P. 
chloranthos (0.58; 1.57; 0.38; and 4.83 mg/mL, 
respectively Table 1. When liposomes were used 
as lipid substrate, the capacity for preventing their 
peroxidation was better in the presence of A. 
vulgaris extract (IC50 = 0.06 mg/mL), nevertheless 
in the presence of liver homogenate, P. chloranthos 
extract had a higher capacity for preventing its 
oxidation (IC50 = 0.36 mg/mL). In addition, in the 
presence of egg yolk, the activities of both extracts 
were not significantly different Table 1. It is 
noteworthy the different ability of both extracts to 
act as antioxidants depending on the lipidic 
substrate. In the presence of liver homogenate, both 
extracts had poorer antioxidant activity than in the 
remaining lipid substrates. P. chloranthos extract 
had higher ability for inhibiting lipoxygenase (IC50 
= 0.02 mg/mL) than A. vulgaris (IC50 = 0.04 
mg/mL) Table 1. 
Since, the activity unities are in all cases the same, 
IC50 values; it is possible to compare the 
effectiveness of samples as antioxidants in the 
diverse assays. The antioxidant activity is highly 
dependent on the method used. For example, and 
by descending order, the antioxidant activity of P. 
chloranthos extract was: lipoxygenase inhibition > 
prevention of lipid peroxidation in the presence of 
liposome or egg yolk homogenate > prevention of 
lipid peroxidation in the presence of liver 
homogenate > hydroxyl scavenging activity > 
DPPH scavenging activity > ABTS scavenging 
activity > superoxide scavenging activity > NO 
scavenging activity. For A. vulgaris extract, the 
order was: lipoxygenase inhibition or prevention of 
lipid peroxidation in the presence of liposome > 
ABTS scavenging activity or hydroxyl scavenging 
activity > DPPH scavenging activity > superoxide 
scavenging activity or prevention of lipid 
peroxidation in the presence of liver homogenate 
NO scavenging activity. 
 
FIG. 1: REDUCING POWER OF A. VULGARIS AND P. 
CHLORANTHUS EXTRACTS 
Nasr et al., IJPSR, 2020; Vol. 11(2): 605-614.                                               E-ISSN: 0975-8232; P-ISSN: 2320-5148 
International Journal of Pharmaceutical Sciences and Research                                                                                610 
Fig. 1 presents the reducing power of A. vulgaris 
and P. chloranthos extracts. Higher absorbance 
means better capacity for reducing Fe
3+
, and 
according to the results A. vulgaris extract had a 
better capacity for reducing these ions than P. 
chloranthos extract. 
DISCUSSION: Solvent extraction is the method 
predominantly used for preparing extracts from 
plant material 
43
. In the present work, the solvent 
used was water and the extraction method was 
decoction. With this procedure, the secondary 
metabolites extracted will be predominantly 
hydrophilic compounds. Generally, medicinal 
plants when used as folk medicines, and per os, 
were under aqueous form and not under other way 
using organic solvents, either an infusion or 
decoction. For this reason, water was the choice 
solvent, and decoction, the extraction method. 
For evaluating lipid peroxidation, several substrates 
may be used such as homogenous lipids (fats and 
oils), or aqueous microheterogenous systems 
(micelles, liposomes) 
44
. In the present work, pork 
liver homogenates, egg yolk and liposomes 
containing lecithin were used as lipid substrates. 
Lecithin liposomes were used as a model-system of 
biological membranes 
45
. The modified 
Thiobarbituric Acid Reactive Species (TBARS) 
was the method used for measuring the antioxidant 
effectiveness of extracts.  
Both aqueous extracts possessed the capacity for 
preventing lipid peroxidation, nevertheless such 
ability was dependent on the extract and lipidic 
substrate as well Table 1. The effectiveness of both 
extracts to prevent lipid peroxidation of liver was 
much weaker than those lipids of egg yolk or 
liposomes. Such difference may be correlated to the 
different lipidic profile of the substrate, as 
previously reported by some authors 
46
 when 
studying the antioxidant activity of essential oils, 
isolated from diverse aromatic plants, on egg yolk, 
chicken or rat livers. Generally, the antioxidant 
activity was associated with the amount of phenols 
in samples as well as with their structures, along 
with the method of antioxidant determination 
used 
43, 47
.  
In the present work, two extracts obtained from two 
plants, using the same extraction procedure, had 
different amounts of phenols and distinct behaviors 
as antioxidants depending on the lipid substrates 
used. For example, P. chloranthus had a stronger 
ability to prevent lipid oxidation of liver, whilst A. 
vulgaris extract was a better antioxidant in the 
presence of liposomes (p<0.001; t-Student). In the 
case of egg yolk as lipidic substrate, there were no 
differences between extracts Table 1. These 
differences cannot only be attributed to the 
different phenol concentration of extracts (1.36 mg 
GAE/g and 0.91 mg GAE/g for P. chloranthus and 
A. vulgaris respectively). The amount of total 
phenol detected in A. vulgaris extract was within 
the range to that reported by 
48
 for methanolic 
extracts Table 1 and 2. P. chloranthus extract of 
the present work had higher amounts of total 
phenols (1.36 mg GAE/g) when compared to those 
previously reported Table 1. 
The capacity for scavenging free radicals was also 
dependent on the extracts and type of radicals 
assayed. A. vulgaris extract was the best scavenger 
of almost all free radicals (p<0.001, t-Student) 
although its lower concentration of total phenols 
than P. chloranthus extract, with the exception of 
DPPH free radicals in which there were no 
differences between the extract Table 1.  
After the research with the words "Artemisia 
vulgaris antioxidant" made in Web of Knowledge, 
it was possible to find the references listed in Table 
2. According to the table, the capacity for 
scavenging DPPH free radicals (eight references) 
was the method mainly used by the authors, 
followed by FRAP (Ferric Reducing Antioxidant 
Power) (four references), ABTS method (two 
references) and finally TBARS, ORAC (Oxygen 
Radical Absorbance Capacity), NO and total 
antioxidant activity (one reference each).  
Percentages of inhibition and IC50 values were 
ways to present the results for the DPPH method, 
and we can only compare our results with those 
also expressed as IC50 values. The results obtained 
in the present work (IC50 = 0.47 mg/mL) were 
closer to those found by 
25
. Temraz and El-
Tantawy 
34
 found IC50 = 11.4 g/mL, much lower 
(and consequently much higher activity) than that 
obtained in the present work, though having the 
same extraction solvent used.  
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TABLE 2: REVIEW OF THE ANTIOXIDANT ACTIVITY OF A. VULGARIS AND P. CHLORANTHUS EXTRACTS 
Artemisia vulgaris 
Extract Method Total phenol content Units Activity Units 
Hydroalcoholic 
Hydroalcoholic 25 
DPPH 
TBARS (egg yolk)  
28.62 
28.62 
mg GAE/g 
mg GAE/g 
IC50 = 976 
IC50 = 0.36 
g/mL 
mg/mL 
Methanol 
Methanol 16 
DPPH 
ORAC  
7920 
7920 
µg GAE/g 
µg GAE/g 
IC50 = 16 
5700 
µg/mL 
µmol Trolox/g 
Methanol 
Methanol 24 
DPPH 
ABTS  
217.46 
217.46 
mg GAE/L 
mg GAE/L 
43.3% 
TEAC* = 4.40 
0.25 mg/4 mL 
mM/mg 
Methanol 47 DPPH  CE: 141.9 
UE: 135.0 
SE: 123.4 
mg GAE/g 
mg GAE/g 
mg GAE/g 
CE: IC50 = 22.2 
UE: IC50 = 26.5 
SE: IC50 =28.1 
g/mL 
Methanol 52 DPPH 321.23 mg GAE/g 92.33% * 
Aqueous 
Aqueous 34 
DPPH 
NO  
19 
19 
mg GAE/g 
mg GAE/g 
IC50 = 11.4 (19) 
IC50 = 125 
g/mL 
mg/mL 
Methanol 
Methanol 48 
ABTS 
FRAP  
956 
956 
g GAE/g 
µg GAE/g 
TEAC = 2.86 
2.12 
mol Trolox/g 
µmol Fe2
+/g 
HA-1 53 
HA-2 
HA-3 
HA-4 
HA-5 
HA-6 
HA-7 
HA-8 
HA-9 
 
HA-1 
HA-2 
HA-3 
HA-4 
HA-5 
HA-6 
HA-7 
HA-8 
HA-9 
 
HA-1 
HA-2 
HA-3 
HA-4 
HA-5 
HA-6 
HA-7 
HA-8 
HA-9 
DPPH  
 
 
 
 
 
 
 
 
 
FRAP 
 
 
 
 
 
 
 
 
 
Total antioxidant 
activity 
18.17 
9.24 
17.28 
9.37 
11.90 
11.36 
13.27 
26.29 
25.81 
g GAE/mg 
g GAE/mg 
g GAE/mg 
g GAE/mg 
g GAE/mg 
g GAE/mg 
g GAE/mg 
g GAE/mg 
g GAE/mg 
 
 
>.40 and < 50 
 
 
 
 
 
 
 
>.80 and < 90 
%inhibition >.8
0 
 
> 130 and < 140 
 
 
 
 
 
 
 
> 170 and < 180 
> 170 and < 180 
> 90 and < 100 
>80 and < 90 
>90 and < 100 
>80 and < 90 
>90 and < 100 
Percentage inhibition 
 
 
 
 
 
 
 
Percentage inhibition 
Percentage inhibition 
 
Ascorbic acid equivalent (mg/mL) 
 
 
 
 
 
 
 
Ascorbic acid equivalent (mg/mL) 
Ascorbic acid equivalent (mg/mL) 
Ascorbic acid equivalent (mg/mL) 
Ascorbic acid equivalent (mg/mL) 
Ascorbic acid equivalent (mg/mL) 
Ascorbic acid equivalent (mg/mL) 
Ascorbic acid equivalent (mg/mL) 
Methanol 54 DPPH 
 
FRAP 
86.62 mg GAE/g 80 
 
2.104 
Percentage inhibition (at 100 μg/mL) 
Absorbance ( = 700 nm), at 
1000 μg/mL 
Methanol 55 FRAP  Roots: >40 and < 50 
Leaves: > 70 and < 80 
Inflorescences: > 100 
and < 110 
mg GAE/g > 7 and < 8 
> 9 and < 10 
>10 and < 15 
M FeSO4/mg 
M FeSO4/mg 
M FeSO4/mg 
Pituranthos chloranthus 
Methanol 
Aqueous 15 
DPPH 
DPPH  
77.59 
91.03 
g/mg 
µg/mg 
IC50 = 71.67 
IC50 = 56.67 
g/mL 
µg/mL 
Hexane 
Ethyl acetate 
Methanol 
Water 14 
DPPH 
DPPH 
DPPH 
DPPH  
117 
380 
317 
372 
mg PyE/100 g 
mg PyE/100 g 
mg PyE/100 g 
mg PyE/100 g 
IC50 = 2.22 
IC50 = 2.24 
IC50 = 2.01 
IC50 = 4.59 
µg/mL 
µg/mL 
µg/mL 
µg/mL 
Hexane 
Ethyl acetate 
Methanol 
Water 14 
ABTS 
ABTS 
ABTS 
ABTS  
117 
380 
317 
372 
mg PyE/100 g 
mg PyE/100 g 
mg PyE/100 g 
mg PyE/100 g 
TEAC = 0.20 
TEAC = 0.36 
TEAC = 0.75 
TEAC = 0.40 
mM Trolox equivalent of extract 
CE: classical extraction; FRAP: Ferric Reducing Antioxidant Power; GAE: Gallic Acid Equivalent; ORAC: Oxygen Radical Absorbance capacity; 
PyE: Pyrogallol equivalent; SE: Sohlet extraction; TEAC: Trolox equivalent antioxidant capacity; UE: ultrasound extraction.  
*The concentration responsible for this percentage is not given 
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The capacity for scavenging ABTS free radicals 
obtained in the present work is not possible to 
compare to those presented in Table 2 since the 
ways used to express the activities are different. 
The capacity for scavenging NO radicals, 
expressed as IC50 values, observed by 
34
 for the 
aqueous extracts was significantly lower than our 
extracts (IC50 = 4.83 mg/mL), therefore presenting 
higher activity. 
The same research made for A. vulgaris was 
repeated for P. chloranthus in Web of Knowledge, 
but in this case, no reference was found. Only 
research using Google allowed finding references; 
some of them are listed in Table 2. The capacity 
for scavenging DPPH and ABTS free radicals were 
the methods preferentially used by the authors. The 
activities found by the authors were 6 - 200-fold 
higher than those found in the present work. 
Compounds that inhibit lipoxygenase may 
possibly prevent the formation of peroxides from 
unsaturated fatty acids containing a Z,Z-1,4-
pentadiene system, and consequently the 
biosynthesis of leukotrienes that play an important 
role in inflammatory processes 
49
. Such compounds 
have antioxidant and anti-inflammatory activity. 
The extracts of A. vulgaris and P. chloranthus had 
capacity for inhibiting lipoxygenase, although P. 
chloranthus possessed higher activity than A. 
vulgaris extract (p<0.01, t-Student). 
P. chloranthus extract revealed to be better 
antioxidant acting through the inhibition of 
lipoxygenase and prevention of lipid peroxidation 
when the lipid substrate was liver than as 
scavenging free radicals Table 1. Among all tests 
assayed, the capacity for inhibiting lipoxygenase 
activity was also the best for A. vulgaris extract, 
followed by the inhibition of lipid peroxidation 
when using egg yolk and liposomes as lipidic 
substrates. In addition, this extract had also good 
capacity for scavenging hydroxyl and ABTS free 
radicals, not observed for P. chloranthus Table 1. 
The antioxidant activities of P. chloranthus and A. 
vulgaris aqueous extracts, measured through 
diverse methods, found in the present work, were 
generally poorer when compared to the positive 
controls assayed in our laboratory in another time 
period 
50, 51
. Briefly, the IC50 values found for BHT 
(butylated hydroxytoluene) used as positive control 
in ABTS, DPPH; TBARS (egg yolk as liposomes 
used as substrate) methods were 0.004 mg/mL; 
0.089 mg/mL; 0.096 mg/mL; and 0.002 mg/mL, 
respectively. These values were lower than those 
obtained for plant extracts Table 1. Ascorbic acid 
used was used as positive control in the evaluation 
of the ability for scavenging superoxide anion 
radicals. The IC50 value was lower (better activity) 
(0.017 mg/mL) than the plant extracts Table 1. The 
IC50 value of mannitol, the positive control for the 
determination of the ability for scavenging 
hydroxyl radicals, was 0.0007 mg/mL, much lower 
(much better activity) than the samples Table 1. 
Nordihydroguaiaretic acid (NDGA) was the sole 
positive control studied in which the respective 
IC50 value was the same as that of P. chloranthus 
extract (IC50 = 0.02 mg/mL) Table 1.  
CONCLUSION: The results observed in the 
present work not only show that there are 
differences of antioxidant activity between A. 
vulgaris and P. chloranthus extracts, but also the 
strength for inhibiting the oxidation is highly 
dependent on the method used, that is, it is possible 
to have samples that show better capacity for 
scavenging some free radicals and lower activity 
for scavenging other ones or preventing lipid 
peroxidation and vice-versa. The evaluation of the 
antioxidant activity of one sample can be a time-
consuming process since several methods based in 
several mechanisms must be assayed. The 
oxidation process involves several steps and 
mechanisms, therefore diverse based-mechanisms 
assays must be done. 
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